On average, the cost of bringing a biologic therapy to market is $2.8 billion with a timeline of 10 years or more. As the biologics… Read more
Nsight Barbara Nelsen on the business of science.
Like Pig Pen of Charles Schulz’s Peanuts, you are constantly moving about in an undulating cloud of your own making. The good news? This cloud… Read more
As the cell therapy industry grows, so does the realization that biomanufacturing processes are critical to it’s clinical and commercial success. The challenge lies in that each… Read more
Dividing my time between Minnesota, Boston, and Chicago means I get to meet new people and organizations every week. Here are some great connections for… Read more
Money MattersFiled under Life science, Startup financing, Venture capital
With JP Morgan fast approaching, as well as the Biotech Showcase and Medtech Showcases and RESI, all in the same few days of January, we have… Read more